Skip to main content
Premium Trial:

Request an Annual Quote

Novo Nordisk Licenses TET Systems' Gene Expression Tech

NEW YORK (GenomeWeb News) – Novo Nordisk has licensed gene expression technology from TET Systems for use in its research activities, TET Systems said.

Under the agreement, Novo Nordisk will use TET Systems technology at the Hagedorn Research Institute, which handles the drug developer's internal research activities.

Heidelberg, Germany-based TET Systems holds six patent families of intellectual property covering methods to control gene expression in higher organisms.

Financial terms of the agreement were not released.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.